(Reuters) -The U.S. Food and Drug Administration has issued a warning letter to Philips after inspections at three of its medical device facilities found they had failed to meet required manufacturing standards, according to an update on the agency’s website on Tuesday.
(Reporting by Sruthi Narasimha Chari and Kamal Choudhury in Bengaluru)
Comments